Pharmafile Logo
Pharmafocus logo
Advanced Search
ABPI

Barker praises OLS model

February 5, 2010
Research and Development, Sales and Marketing ABPI, Blueprint, OLS

The ABPI’s director general spoke to Pharmafocus about the promise of the new Blueprint at its launch in London last …

News
Andrew Witty

GSK confirms job cuts but avoids specifics

February 5, 2010
Research and Development, Sales and Marketing 2009 financials, GlaxoSmithKline

GlaxoSmithKline has sidestepped questions about the internal fall-out from its new plan to slash R&D infrastructure costs. Presenting the company’s …

News
Photo_Miguel_Forte300dpi

Miguel Forte joins TxCell

February 5, 2010
Research and Development TxCell, appointment, research and development

French biotech TxCell has appointed Miguel Forte to fill its newly-created role of chief medical officer. Miguel joins the company …

Appointment

Portfolio Harmony in five easy steps

February 5, 2010
Sales and Marketing product portfolio

Portfolio planning should be a practical process that delivers a programme of work to take you to sunnier shores. All …

Feature

Zeftera problems weigh down Basilea

February 5, 2010
Sales and Marketing 2009 financials, Basilea, Zeftera

Specialist Swiss pharma company Basilea has announced a doubling of its revenues in 2009, thanks to the launch of its …

News

GSK acquires respiratory candidate

February 4, 2010
Research and Development Apeiron, GlaxoSmithKline, respiratory

GlaxoSmithKline has acquired exclusive rights to a biotherapeutic enzyme developed for use against Acute Respiratory Distress Syndrome (ARDS). The move …

News
Pfizer World

Wyeth acquisition yet to shake Pfizer’s Lipitor dependence

February 4, 2010
Sales and Marketing 2009 financials, Lipitor, Pfizer

Pfizer’s profits rose by 7% last year on the back of a 4% increase in revenue driven by cholesterol treatment …

News

Fishawack makes US acquisition

February 4, 2010
Medical Communications Nexus Communications, fishawack

Cheshire-based healthcare agency Fishawack Communications has bought US outfit Nexus Communications. The company says this acquisition is part of a …

News

Oxford Immunotec appoints Frank Vandeputte

February 4, 2010
Sales and Marketing Oxford Immunotec, appointment, medical devices, sales and marketing

Medical diagnostics company Oxford Immunotec has appointed Frank Vandeputte vice president, sales and marketing. He was formerly VP, Europe for …

Appointment

Eden Biodesign passes into Watson Pharma’s hands

February 4, 2010
Manufacturing and Production Eden Biodesign, Watson Pharma, biologicals

UK biologics manufacturing specialist Eden Biodesign has been bought by US drugmaker Watson Pharmaceuticals in a $15 million deal. The …

News

Lancet retracts MMR research conclusions

February 3, 2010
Research and Development MMR, Sanofi, vaccines

The Lancet, the journal which originally published the controversial research linking the MMR vaccine to autism has issued a full …

News

Digital Pharma: New EMA website previewed

February 3, 2010
Research and Development, Sales and Marketing EMA, branding, digital pharma

The European Medicines Agency is preparing to overhaul its website to make it easier for users to get information. This …

News

Digital added to PM’s as Langland clean up

February 3, 2010
Medical Communications Langland, awards, pm society

Langland swept the board at the PM Society’s Advertising Awards on 29 January with seven wins across 20 award categories. …

News

FDA to assess Neupogen biosimilar

February 3, 2010
Research and Development, Sales and Marketing Hospira, Teva, biosimilars

US regulator the FDA has agreed to assess Teva’s application for a biosimilar version of Amgen’s Neupogen (filgrastim). XM02, a …

News
Roche building

Genentech integration hits Roche profits

February 3, 2010
Sales and Marketing 2009 financials, Genentech, Roche

Roche achieved healthy sales growth in 2009 but saw a 22% drop in net income due to the cost gaining …

News

Talking Careers: The brief has changed

February 2, 2010
Business Services Talking Point, interim management, rsa, talking careers

Planning for the future is crucial at any time, but particularly when the market has changed and contracted as the …

Feature

Brennan maintains support for US reforms

February 2, 2010
Sales and Marketing Obama, US healthcare

David Brennan has reiterated the industry’s early support for President Obama’s healthcare plans, but acknowledged the recent election of a …

News

Parexel sees signs of recovery in Q2 figures

February 2, 2010
Research and Development CRO, Parexel

Contract research organisation Parexel International’s second-quarter net profit fell 34% to $3.5 million on restructuring and investment-impairment charges, but still …

News

Novo buoyed by insulin portfolio

February 2, 2010
Sales and Marketing 2009 financials, Novo Nordisk, Victoza

Danish pharma company Novo Nordisk managed a double-digit rise in sales and profits in 2009, buoyed by insulin products NovoRapid, …

News

Job cuts at GlaxoSmithKline and AstraZeneca

February 2, 2010
Research and Development, Sales and Marketing AstraZeneca, GlaxoSmithKline

Britain’s two biggest pharma companies GlaxoSmithKline and AstraZeneca are poised to make deep job cuts as business models continue to …

News
The Gateway to Local Adoption Series

Latest content

Alto Neuroscience announces new patent for depression treatment

January 15, 2026

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026